Standard BioTools Sells Microfluidics Business to Archimed
Standard BioTools has agreed to sell its Microfluidics business to Archimed, an investment firm focused on healthcare industries. The Microfluidics technology enables experiments at a scale not possible with traditional benchtop methods.